WASHINGTON, July 16 — The Federal Trade Commission building hums with a quiet intensity this morning, the kind that precedes a regulatory storm. Inside, staff attorneys are reviewing a growing stack of consumer complaints, the latest front in a battle over wearable tech and the data these devices silently collect. The FTC, an independent agency born from the trust-busting fervor of 1914, was Congress’s answer to the monopolistic crises of the 19th century.
Congress passed the Federal Trade Commission Act, creating a body with a principal mission: enforcement of civil antitrust law and consumer protection. Today, that mission is being tested in new territory.
At the heart of the current debate is how the agency uses its broad statutory authority. The FTC shares jurisdiction over federal civil antitrust law enforcement with the Antitrust Division of the U.S. Department of Justice. Its five commissioners, nominated by the president and confirmed by the Senate, serve seven-year terms.
Historically, those commissioners could only be removed for “inefficiency, neglect of duty, or malfeasance in office,” a standard that shifted after the Supreme Court’s 2026 ruling. The agency enforces the Clayton Act and the FTC Act, codified in 15 U.S.C. § 41 et seq.
Over time, Congress has delegated enforcement of additional business regulation statutes, and the FTC has promulgated regulations now codified in Title 16 of the Code of Federal Regulations. The broad statutory authority granted to the FTC provides it with more surveillance and monitoring abilities than it actually uses. That gap between legal power and practical enforcement is central to the current policy discussions.
By nightfall, consumer advocacy groups are pointing to the wearable tech sector. The concern is straightforward: companies may mislead consumers about how health and location data are collected, used, or shared. The FTC’s role in enforcing consumer protection laws against such deceptive practices is a key topic in ongoing policy discussions.
The agency’s headquarters, the Federal Trade Commission Building in Washington, D.C., is the nerve center. From there, the commission can deploy its authority to investigate and punish deceptive trade practices.
The question now is whether it will choose to do so more aggressively in the digital health space. What happens next will depend on the commissioners themselves. With the Supreme Court’s 2026 ruling changing the standard for their removal, the political dynamics inside the agency have shifted.
For now, the FTC’s enforcement of the Clayton Act and the FTC Act remains the primary tool for reining in deceptive data practices. The scene inside the building is one of methodical preparation.
Staff are sifting through the evidence, weighing which cases to pursue. The agency has the legal authority to act. The debate is over how much of that authority it will actually use.
